Skip to content

Clinical trials

Completed Burkitt Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Burkitt Lymphoma Status: Completed Clear all

508 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200042
200118
200231
200326
200431
200529
200627
200726
200819
200916
201014
201117
20129
201314
20145
20154
201610
201710
20185
20196
20205
20215
20221
20234

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed508

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)80
Fred Hutchinson Cancer Center46
Memorial Sloan Kettering Cancer Center20
Case Comprehensive Cancer Center18
Children's Oncology Group18
Mayo Clinic13
National Institutes of Health Clinical Center (CC)13
Roswell Park Cancer Institute13
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins13
City of Hope Medical Center12

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma508
Lymphoma, Large B-Cell, Diffuse389
Precursor Cell Lymphoblastic Leukemia-Lymphoma378
Lymphoma, Follicular364
Lymphoma, Mantle-Cell355
Lymphoma, Non-Hodgkin344
Lymphoma, Large-Cell, Immunoblastic329
Lymphoma, B-Cell, Marginal Zone325
Leukemia, Lymphocytic, Chronic, B-Cell324
Lymphoma303

Trials

Showing 51 to 75 of 508. Each trial links to its page on Pharma Observatory.

408 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.